Teva shares slide as it faces illegal kickback charges from US government

Teva shares slide as it faces illegal kickback charges from US government

Source: 
Pharmaforum
snippet: 

Shares in Teva were down sharply this week after the US Department of Justice filed a complaint that the company paid illegal kickbacks to patient groups to boost sales of its multiple sclerosis drug Copaxone (glatiramer).